Abbott (ABT) Reports In-Line Q4 EPS; offers guidance
Get Alerts ABT Hot Sheet
Price: $108.33 -0.42%
Revenue Growth %: +14.2%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.2%
Financial Fact:
Interest expense: 117M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.50, in-line with the analyst estimate of $1.50. Revenue for the quarter came in at $11.46 billion versus the consensus estimate of $11.8 billion.
GUIDANCE:
Abbott sees Q1 2026 EPS of $1.12-$1.18, versus the consensus of $1.20.
Abbott sees FY2026 EPS of $5.55-$5.80, versus the consensus of $5.17.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share